
Grifols completes development of molecular test to detect SARS-CoV-2 virus
Catalan Economy
06 May 2020
“Having sufficient molecular test capacity is critical to helping control this pandemic, and having a high-sensitivity test to handle a possible ‘pooling’ strategy is, without a doubt, a differentiating factor, which could make it feasible,” said Victor Grifols Deu, Grifols co-CEO in the company’s press release.
Grifols began developing its test to detect SARS-CoV-2 the first week of February, through its teams in San Diego, Bilbao and Barcelona.
Source: Grifols
Related News and Success stories.
-
10 Mar 2025
Catalonia Trade & Investment breaks records with over €1B in foreign investment attracted in 2024
-
07 Mar 2025
MWC25 draws 109,000 attendees in Barcelona for a week of AI and innovation
-
25 Feb 2025
2024 Breaks Records for Catalan Startups with 2,285 Companies
-
18 Feb 2025
Catalonia’s health startups and scaleups set investment record, rising 55% from last year